Novozymes wins Chinese patent case after protracted court battle

The Supreme People's Court of China has ruled in favor of Novozymes in a case against two Chinese companies.

Photo: Novozymes/ PR

The Danish producer of enzymes and microorganisms Novozymes has won a patent case in China which thus marks the end of a court battle which has been ongoing for the past five-six years, writes Novozymes in a press release.

The case began in 2011 when Novozymes found evidence that the two companies, Shandong Longda Bio-Products and Jiangsu Boli Bioproducts, were selling an enzyme for which Novozymes had Chinese patent protection.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Price cap on gas in Europe is a complex issue and potentially very costly

European lawmakers demand action to rein in gas prices, and the EU Commission has drafted a plan. However, gas prices constitute tricky puzzle: No matter how it’s approached, Europe faces an energy shortage in the next six months. The only way to help consumers is through aid, but this is a potentially costly and dangerous path, says analyst.

Further reading

Related articles

Latest News

See all jobs